S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Stock market today: Global markets are mixed as Middle East tensions escalate
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
Did You Miss the Gold Rush? Try These 2 Silver Stocks
Novo Nordisk Arms Wegovy to Be a Triple Threat
Citi’s Results Say This About The Stock Market
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Stock market today: Global markets are mixed as Middle East tensions escalate
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
Did You Miss the Gold Rush? Try These 2 Silver Stocks
Novo Nordisk Arms Wegovy to Be a Triple Threat
Citi’s Results Say This About The Stock Market
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Stock market today: Global markets are mixed as Middle East tensions escalate
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
Did You Miss the Gold Rush? Try These 2 Silver Stocks
Novo Nordisk Arms Wegovy to Be a Triple Threat
Citi’s Results Say This About The Stock Market
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Stock market today: Global markets are mixed as Middle East tensions escalate
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
Did You Miss the Gold Rush? Try These 2 Silver Stocks
Novo Nordisk Arms Wegovy to Be a Triple Threat
Citi’s Results Say This About The Stock Market
NASDAQ:OPTN

OptiNose (OPTN) Stock Price, News & Analysis

$1.22
-0.02 (-1.61%)
(As of 04/12/2024 08:52 PM ET)
Today's Range
$1.16
$1.25
50-Day Range
$1.22
$1.94
52-Week Range
$0.90
$2.10
Volume
796,700 shs
Average Volume
538,569 shs
Market Capitalization
$137.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.00

OptiNose MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
227.9% Upside
$4.00 Price Target
Short Interest
Healthy
2.76% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-2.10
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Selling Shares
$138,078 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.26) to ($0.12) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.14 out of 5 stars

Medical Sector

143rd out of 928 stocks

Pharmaceutical Preparations Industry

50th out of 417 stocks

OPTN stock logo

About OptiNose Stock (NASDAQ:OPTN)

OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase IIIb clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. It has a license agreement with Currax Pharmaceuticals LLC for the commercialization of Onzetra Xsail. The company was founded in 2000 and is headquartered in Yardley, Pennsylvania.

OPTN Stock Price History

OPTN Stock News Headlines

Biden to Launch “FedNOW” [Move Your Money Now]
Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...
Claim Your Complimentary Bitcoin Reward
Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.
OptiNose: Q4 Earnings Snapshot
OptiNose's Earnings: A Preview
3 Pharma Stocks to Consider for March Gains
See More Headlines
Receive OPTN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OptiNose and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/07/2024
Today
4/15/2024
Next Earnings (Estimated)
5/09/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:OPTN
Fax
N/A
Employees
132
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$4.00
High Stock Price Target
$5.00
Low Stock Price Target
$3.00
Potential Upside/Downside
+227.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$-35,480,000.00
Pretax Margin
-49.99%

Debt

Sales & Book Value

Annual Sales
$70.99 million
Book Value
($0.77) per share

Miscellaneous

Free Float
110,174,000
Market Cap
$137.43 million
Optionable
Not Optionable
Beta
-0.24
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

OPTN Stock Analysis - Frequently Asked Questions

Should I buy or sell OptiNose stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OptiNose in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" OPTN shares.
View OPTN analyst ratings
or view top-rated stocks.

What is OptiNose's stock price target for 2024?

3 brokerages have issued 12-month target prices for OptiNose's stock. Their OPTN share price targets range from $3.00 to $5.00. On average, they predict the company's share price to reach $4.00 in the next twelve months. This suggests a possible upside of 227.9% from the stock's current price.
View analysts price targets for OPTN
or view top-rated stocks among Wall Street analysts.

How have OPTN shares performed in 2024?

OptiNose's stock was trading at $1.29 on January 1st, 2024. Since then, OPTN shares have decreased by 5.4% and is now trading at $1.22.
View the best growth stocks for 2024 here
.

When is OptiNose's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our OPTN earnings forecast
.

How were OptiNose's earnings last quarter?

OptiNose, Inc. (NASDAQ:OPTN) released its quarterly earnings data on Thursday, March, 7th. The company reported ($0.09) earnings per share for the quarter, topping the consensus estimate of ($0.10) by $0.01. The business earned $19.87 million during the quarter, compared to the consensus estimate of $19.90 million. During the same period last year, the company posted ($0.17) EPS.

What guidance has OptiNose issued on next quarter's earnings?

OptiNose issued an update on its first quarter 2024 earnings guidance on Thursday, March, 7th. The company provided EPS guidance of for the period. The company issued revenue guidance of $13.0 million-$13.0 million, compared to the consensus revenue estimate of $18.2 million.

What other stocks do shareholders of OptiNose own?
When did OptiNose IPO?

OptiNose (OPTN) raised $101 million in an initial public offering on Friday, October 13th 2017. The company issued 6,300,000 shares at $15.00-$17.00 per share. Jefferies, Piper Jaffray, BMO Capital Markets and RBC Capital Markets acted as the underwriters for the IPO.

How do I buy shares of OptiNose?

Shares of OPTN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:OPTN) was last updated on 4/15/2024 by MarketBeat.com Staff

From Our Partners